doi:10.1016/j.addr.2021.113869 49
People with certain conditions, or who are pregnant or breastfeeding, should hold off, which is exactly the kind of thing we screen for before treating
Another major issue is the quality of the medication itself
As of mid-2026 it has generated substantial phase 2 and phase 3 data across obesity and type 2 diabetes, and Lilly has reported it as the first oral small-molecule GLP-1 receptor agonist to complete phase 3 trials
Resistance training: Include strength exercises 2-3 times weekly to preserve muscle mass
When we included LiPA results for those samples in which sequencing was not done, overall agreement at the subtype level (with either LiPA or sequencing) even slightly increased to 98.6% (140/142), as the agreement at HCV-1 subtype calling between the GT Plus and the LiPA assays was 100% (all being 1b except one 1a case)